Clinical Trials · NCT04064411
Efficacy & Safety of Abaloparatide-Solid Microstructured Transdermal System in Postmenopausal Women With Osteoporosis
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Radius Health, Inc.
- Enrollment
- 511
- Start date
- Aug 2019
- Locations
- 97 sites, 5 countries
- Primary endpoint
- Percent Change From Baseline in Lumbar Spine BMD at Month 12